These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 8345076)

  • 21. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
    Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
    Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
    Swahn ML; Bygdeman M; Seppälä M; Johannisson E; Cekan S
    Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle.
    Croxatto HB; Salvatierra AM; Croxatto HD; Fuentealba B
    Hum Reprod; 1993 Feb; 8(2):201-7. PubMed ID: 8473419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mifepristone on inhibition of ovulation and induction of luteolysis.
    Spitz IM; Croxatto HB; Lähteenmäki P; Heikinheimo O; Bardin CW
    Hum Reprod; 1994 Jun; 9 Suppl 1():69-76. PubMed ID: 7962472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol.
    Swahn ML; Bygdeman M; Chen JK; Gemzell-Danielsson K; Song S; Yang QY; Yang PJ; Qian ML; Chang WF
    Hum Reprod; 1999 Feb; 14(2):485-8. PubMed ID: 10099999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
    Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
    Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
    Ghosh D; Nayak NR; Sengupta J
    Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis.
    Telleria CM; Mezzadri MR; Deis RP
    Contraception; 1997 Oct; 56(4):267-74. PubMed ID: 9408709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteal contraception.
    Yen S; Garzo G; Liu J
    Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone: a potential contraceptive.
    Heikinheimo O; Archer DF
    Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.